<var id="1lrzf"></var>
<var id="1lrzf"><strike id="1lrzf"></strike></var>
<var id="1lrzf"></var><var id="1lrzf"><strike id="1lrzf"></strike></var>
<var id="1lrzf"><strike id="1lrzf"></strike></var><menuitem id="1lrzf"></menuitem>
<var id="1lrzf"><strike id="1lrzf"><listing id="1lrzf"></listing></strike></var>

Full text: Rome Declaration of Global Health Summit

Comment(s)打印 E-mail China.org.cn 2021-05-25


We, Leaders of G20 and other states, in the presence of the Heads of international and regional organisations meeting at the Global Health Summit in Rome, May 21, 2021, having shared our experience of the ongoing global COVID-19 pandemic, and welcoming relevant work in this regard, including that presented during the pre-Summit, today:


Reaffirm that the pandemic continues to be an unprecedented global health and socio-economic crisis, with disproportionate direct and indirect effects on the most vulnerable, on women, girls and children, as well as on frontline workers and the elderly. It will not be over until all countries are able to bring the disease under control and therefore, large-scale, global, safe, effective and equitable vaccination in combination with appropriate other public health measures remains our top priority, alongside a return to strong, sustainable, balanced and inclusive growth.


Convey our condolences for lives lost and express our appreciation for healthcare and all frontline workers' vital efforts in responding to the pandemic.


Welcome the World Health Organization's (WHO) designation of 2021 as the Year of Health and Care Workers, and reaffirm our full support for the leading and coordinating role of the WHO in the COVID-19 response and the broader global health agenda.


Underline that sustained investments in global health, towards achieving Universal Health Coverage with primary healthcare at its centre, One Health, and preparedness and resilience, are broad social and macro-economic investments in global public goods, and that the cost of inaction is orders of magnitude greater.


Recognise the very damaging impact of the pandemic on progress towards achieving the Sustainable Development Goals (SDG). We reaffirm our commitment to achieving them to strengthen efforts to build back better (as in UNGA resolution, 11th September 2020), and to the International Health Regulations 2005 (IHR), which together will improve resilience and global health outcomes.


Strongly underline the urgent need to scale up efforts, including through synergies between the public and private sectors and multilateral efforts, to enhance timely, global and equitable access to safe, effective and affordable COVID-19 tools (vaccines, therapeutics, diagnostics, and personal protective equipment, henceforth 'tools'). Recognise the necessity to underpin these efforts with strengthened health systems, recalling the G20 extraordinary Summit of 26 March 2020.

認識到將新冠肺炎疫苗作為公共產品進行廣泛接種的作用,我們重申支持該領域所有合作,特別是“全球合作加速開發、生產、公平獲取新冠肺炎防控新工具”倡議(ACT-A)。強調需彌補“倡議”資金缺口,以幫助其履行職責。我們注意到開展全面戰略審議的意愿,在此基礎上可能調整和延長授權至2022年底。強調支持全球共享安全、有效、高質量、可負擔的疫苗,包括在國內條件允許的情況下,同ACT-A疫苗支柱“新冠肺炎疫苗實施計劃”(COVAX)開展合作。歡迎2021年6月舉行“新冠肺炎疫苗預先市場采購承諾機制”(COVAX AMC)峰會,并注意到“公平獲取新冠肺炎工具憲章”。

Recognising the role of extensive COVID-19 immunisation as a global public good, we reaffirm our support for all collaborative efforts in this respect, especially the Access to COVID-19 Tools Accelerator (ACT-A). We underline the importance of addressing the ACT-A funding gap, in order to help it fulfil its mandate. We note the intention to conduct a comprehensive strategic review as basis for a possible adaptation and extension of its mandate to the end of 2022. We emphasise our support for global sharing of safe, effective, quality and affordable vaccine doses including working with the ACT-A vaccines pillar (COVAX), when domestic situations permit. We welcome the June 2021 COVID-19 Vaccines Advance Market Commitment (COVAX AMC) Summit and we note the Charter for Equitable Access to COVID-19 tools.


Note the COVAX Vaccine Manufacturing Working Group, supporting the COVAX Manufacturing Task Force, led by the WHO, the Coalition for Epidemic Preparedness Innovations (CEPI), GAVI and UNICEF, that includes partners such as the World Trade Organisation (WTO) and Medicines Patent Pool. We affirm our support for efforts to strengthen supply chains and boost and diversify global vaccine-manufacturing capacity, including for the materials needed to produce vaccines, including by sharing risks, and welcome the vaccines technology transfer hub launched by the WHO. We ask the Working Group and Task Force to report on their progress to the G20 in time for the Leaders' Summit in October. This report will be informed by the WTO and other international stakeholders and organisations, consistent with their mandates and decision-making rules, on how to improve equitable access in the current crisis.


Applaud the unprecedented achievement of safe and effective COVID-19 vaccines within one year, and highlight the importance of continued investment in research and innovation, including in multilateral and other collaborative efforts, to further accelerate the development of safe and effective tools.


Underline the importance of working with all relevant public and private partners rapidly to increase the equitable availability of tools and to enhance access to them. Short-term options include: sharing existing products, including of vaccines through COVAX; Diversifying production capacity; Identifying and addressing bottlenecks in production; Facilitating trade and transparency across the entire value chain; Promoting increased efficiency in the use of capacities and global distribution by cooperation and expansion of existing capacities, including by working consistently within the TRIPS agreement and the 2001 Doha Declaration on the TRIPS agreement and Public Health; and Promoting the use of tools such as voluntary licencing agreements of intellectual property, voluntary technology and know-how transfers, and patent pooling on mutually-agreed terms.


Welcome high-level political leadership for preparedness and response in relation to health emergencies. Note proposals on a possible international instrument or agreement with regards to pandemic prevention and preparedness, in the context of the WHO, and efforts by the WHO, World Organisation for Animal Health, Food and Agriculture Organisation, United Nations Environment Programme and others in relation to strengthening the implementation of the One Health approach through their One Health High-Level Expert Panel.


Beyond these statements in view of the ongoing pandemic, we set out principles and guiding commitments below. These serve as voluntary orientation for current and future action for global health to support the financing, building, and sustaining of effective health system capabilities and capacities and Universal Health Coverage to improve preparedness, early warning of, prevention, detection, coordinated response, and resilience to, and recovery from, the current pandemic and future potential public health emergencies.


These mutually reinforcing principles reconfirm our commitment to global solidarity, equity, and multilateral co-operation; to effective governance; to put people at the centre of preparedness and equip them to respond effectively; to build on science and evidence-based policies and create trust; and to promote sustained financing for global health. 


Principles of the Rome Declaration


We commit to promote and make tangible progress towards these principles and the action they guide by the G20 Summit in Rome in October and beyond and invite their consideration in the forthcoming World Health Assembly (WHA) and other relevant fora, and by all relevant stakeholders. We will:

1. 考慮到即將召開的世衛大會,以及近期和正在進行的評估進程,包括此前世衛大會授權的評估,支持并加強現有多邊衛生架構以防范、預防、檢測和應對疫情,其核心是有適當、可持續、可預測資金來源且有效運作的世衛組織。支持為所有人實現可持續發展目標、以及《人人享有健康生活和福祉全球行動計劃》等具體倡議,以更好支持各國加快實現健康相關的可持續發展目標,包括全民健康覆蓋。支持實現可持續、包容和有韌性復蘇的目標,逐步推動人人享有可達到的最高健康標準的權利。

1) Support and enhance the existing multilateral health architecture for preparedness, prevention, detection and response with an appropriately, sustainably and predictably funded, effective WHO at its centre, taking account of the forthcoming WHA and various recent and ongoing review processes, including those resulting from the previous WHA. Support the achievement of the SDG, their targets, and specific initiatives such as the Global Action Plan for Healthy Lives and Wellbeing for all to better support countries to accelerate progress towards the health-related SDG including towards Universal Health Coverage. Support the goal of a sustainable, inclusive and resilient recovery that promotes the progressive realisation of the right for all people to the enjoyment of the highest attainable standard of health.

2. 努力并更好支持全面實施、監測和遵守《國際衛生條例》,推動循證的、符合“同一健康”方針的跨部門措施的有效實施,以應對人類-動物-環境交匯及抗微生物藥物耐藥性帶來的風險和威脅,注意到相關國際組織在該領域的作用,鼓勵在與相關衛生組織商討后,推動出臺新的包括郵輪在內的航空和海上國際旅行公共健康指導方案。

2) Work towards and better support the full implementation of, monitoring of and compliance with the IHR, and enhanced implementation of the multi-sectoral, evidence based One Health approach to address risks emerging from the human-animal-environment interface, the threat of anti-microbial resistance, noting the role of relevant international organisations in that regard and encourage new public health guidance in consultation with relevant health organisations on international travel by air or sea, including cruise ships.

3. 采取全社會、健康融入所有政策的措施,包括國家和社區要素相互促進,推動政府最高層負起責任,以達到更好的防范、預防、檢測和應對。

3) Foster all-of-society and health-in-all policies approaches, with mutually reinforcing national and community elements, and promote responsibility at the highest levels of government for the achievement of better preparedness, prevention, detection and response.

4. 推進多邊貿易體制,注意到世界貿易組織的核心作用,以及在全價值鏈中開放、韌性、多樣、安全、高效、可靠的全球供應鏈對突發衛生事件的重要性,包括疫苗生產原材料,及生產和獲取應對突發衛生事件的藥物、診斷、工具、醫療器械、非藥品物資和原材料。

4) Promote the multilateral trading system, noting the central role of the WTO, and the importance of open, resilient, diversified, secure, efficient and reliable global supply chains across the whole value chain related to health emergencies, including the raw materials to produce vaccines, and for the manufacturing of and access to medicines, diagnostic, tools, medical equipment, non-pharmaceutical goods, and raw materials to address public health emergencies.

5. 借鑒ACT-A相關經驗,使人們能夠公平、及時、可負擔地在全球范圍內獲得高質量、安全和有效的預防、檢測和應對工具,以及非藥物措施、清潔水、環境衛生、個人衛生及(充足食物)營養,以及強健、包容和有韌性的衛生系統;并支持建立強有力的疫苗交付系統、增強對疫苗的信心并普及衛生知識。

5) Enable equitable, affordable, timely, global access to high-quality, safe and effective prevention, detection and response tools, leveraging and drawing on the experience of ACT-A, as well as to non-pharmaceutical measures, clean water, sanitation, hygiene and (adequate food) nutrition and to strong, inclusive, and resilient health systems; and support robust vaccine delivery systems, vaccine confidence and health literacy.

6. 支持低收入和中等收入國家加強專業能力建設,發展當地和區域工具生產能力,包括繼續對“新冠疫苗實施計劃”進行投入,以提高全球、區域和地方生產、處理和分配能力。進一步促進衛生技術利用及衛生系統數字化轉型。

6) Support low- and middle-income countries to build expertise, and develop local and regional manufacturing capacities for tools, including by building on COVAX efforts, with a view to developing improved global, regional and local manufacturing, handling and distribution capacities. Further enable increased use of health technologies and the digital transformation of health systems.

7. 發揮相關組織和平臺的協同作用,并基于其專業知識,推動以各方同意的條件開展數據共享、能力建設、許可協議和自愿技術及經驗轉讓。

7) Leverage synergies and build on expertise of relevant organisations and platforms to facilitate data sharing, capacity building, licensing agreements, and voluntary technology and know-how transfers on mutually agreed terms.

8. 加大對現有疫情防范和預防架構的支持力度,針對疫苗可預防疾病推動公平疫苗接種,將上述疾病以及艾滋病、結核、瘧疾等其他傳染性疾病和非傳染性疾病納入監測和衛生計劃,作為提供綜合服務的一部分,確保沒有人掉隊。

8) Enhance support for existing preparedness and prevention structures for equitable immunisation against vaccine preventable diseases, and surveillance and health programmes for these and other diseases, including HIV/AIDS, tuberculosis, malaria and others, and non-communicable diseases, as part of integrated service delivery and ensuring that no one is left behind.

9. 對全球衛生和照護工作者隊伍進行投入,通過包括世衛組織學院等世衛組織相關倡議在內的教育和培訓,提高其得到各國互認的專業能力,以實現更好的健康、加速發展、促進社會包容和性別平等的三重紅利。對社區衛生和衛生系統進行投入,讓所有國家享有更有力、有韌性、包容、高質量的衛生服務、持續護理能力、地方及家庭護理能力及公共衛生能力。對世衛組織領導的多邊機制進行投入,以提高對發展中國家和受危機影響國家的援助和應對能力。對衛生保健設施的水清潔和衛生條件進行投入,減少傳染風險,保障醫護人員安全。

9) Invest in the worldwide health and care workforce, to bring about the triple dividend of better health, acceleration of development, and advancements in social inclusion and gender equality, by developing mutually recognised competencies through education and training including through relevant WHO initiatives including the WHO Academy. Invest in community health and in health systems to achieve strengthened, resilient, inclusive, high quality health services, continuity of care, local and home care, and public health capacities in all countries. Invest in multilateral WHO-led mechanisms to facilitate assistance and response capacities for use in developing and crisis affected countries. Invest also in water sanitation and hygiene in health care facilities to reduce infection risks and safeguard healthcare workers.

10. 對公共和動物衛生診斷實驗室進行投入,為其提供包括基因組測序能力在內的充足資源、培訓機會和人力配備,在發生突發事件時,能夠按照適用法律、現有相關協議、法規和安排快速、安全地向國內外分享數據和樣本。

10) Invest in adequate resourcing, training, and staffing of diagnostic public and animal health laboratories, including genomic sequencing capacity, and rapidly and safely share data and samples during emergencies domestically and internationally, consistent with applicable laws, relevant existing agreements, regulations and arrangements.

11. 對進一步開發、加強和完善符合“同一健康”方針的可互操作的預警信息、監測和觸發系統進行投入。按照《國際衛生條例》相關規定,繼續努力提高潛在疫情暴發數據的監測和分析能力,包括快速、透明地進行跨部門和跨國界的信息和數據共享。

11) Invest in further developing, enhancing and improving inter-operable early warning information, surveillance, and trigger systems in line with the One Health approach. Invest in new efforts to strengthen surveillance and analyse data on potential outbreaks, including rapid and transparent cross-sectoral and international information and data sharing, in accordance with the IHR.

12. 根據國家能力,對衛生系統工具和非藥物措施研究、開發和創新的國內、國際、多邊合作進行可預測、有效、充分的投入,同時從早期階段就開始考慮可擴展性、獲取和制造問題。

12) Invest predictably, effectively and adequately, in line with national capacities, in domestic, international and multilateral cooperation in research, development, and innovation, for health systems tools and non-pharmaceutical measures, considering issues of scalability, access, and manufacturing from an early stage.

13. 在可持續和公平恢復的前提下,統籌推進藥品和非藥品措施、應急響應(包括危機和行動中心的在線協調),以科學建議為基礎對衛生健康、危機防范和應對以及政策制定進行投入。相關政策應有助于加速實現可持續發展目標,解決造成緊急衛生事件的根本原因,包括貧困、結構性不平等、環境惡化等影響健康的社會因素,加強人力資源建設,加快綠色和數字轉型,促進共同繁榮。

13) Coordinate pharmaceutical and non-pharmaceutical measures and emergency response (including online coordination of crisis and operation centres), in the context of a sustainable and equitable recovery, with investment in health, preparedness and response and policies informed by scientific advice. Policies should accelerate progress towards achieving the SDG, combat the root causes of health emergencies, including social determinants of health, poverty, structural inequality and environmental degradation, build human capital, accelerate green and digital transitions, and boost prosperity for all.

14. 支持和促進與當地社區、民間社會、一線工作者、弱勢群體、婦女和其他社會組織以及所有其他利益攸關方進行有意義和包容的對話,抵制錯誤信息、虛假信息,以提高防范和應對措施的有效性。為支持上述工作,應當將準確的信息、證據、不確定因素以及從新冠肺炎疫情和以往突發公共衛生事件中吸取的經驗教訓,以適應當地文化的方式及時向公眾傳遞,以提高治理和決策的透明度,爭取民眾信任。開展健康促進和影響健康的社會因素相關工作,以解決非傳染性疾病、心理健康、糧食與營養等其他關鍵健康問題,提高抵御未來健康危機的整體能力,同時在處理危機時應注意采取年齡和性別敏感的應對方式。

14) Increase the effectiveness of preparedness and response measures by supporting and promoting meaningful and inclusive dialogue with local communities, civil society, frontline workers, vulnerable groups, women's and other organisations and all other relevant stakeholders and by countering misinformation and disinformation. Underpin this with trust and transparency in relation to governance and decision-making, arising from the timely and culturally adapted communication of accurate information, of evidence and of uncertainty, and of lessons learned from the COVID-19 pandemic response and previous public health emergencies. Undertake health promotion and work on the social determinants of health to address other critical health issues such as non-communicable diseases, mental health and food and nutrition, as part of efforts to enhance overall resilience to future health crises and in addition ensure an age- and gender-sensitive response to future crises.

15. 建立強化的、精簡的、可持續的、可預測的融資機制,為大流行病長期防范、預防、監測、應對和快速擴充醫療資源提供資金,能夠以協調、透明、合作的方式,并在強有力的問責和監督下,迅速調動私人和公共資金和資源。加強團結合作,特別是支持疫苗和其他物資生產供應,以及向低收入和中等收入國家提供資金用于疫苗采購。

15) Address the need for enhanced, streamlined, sustainable and predictable mechanisms to finance long-term pandemic preparedness, prevention, detection and response, as well as surge capacity, capable of rapidly mobilising private and public funds and resources in a coordinated, transparent and collaborative manner and with robust accountability and oversight. In a spirit of solidarity, join efforts to support in particular the manufacture and supply of vaccines and other supplies and/or the provision of funding for vaccine purchase, to low- and middle-income countries.

16. 通過采取混合融資,建立創新機制,綜合運用公共、私人和慈善部門以及國際金融機構資金等方式,努力確保上述融資機制有效運作。努力避免工作重復,強調各國需根據自身國情,主要通過國內資源為履行《國際衛生條例》和國內研發能力提供資金,并為那些不具備此能力的國家爭取支持。強調為滿足中低收入國家融資需求進行多邊努力的重要性,包括國際貨幣基金組織提議的新增特別提款權分配方案、富有雄心的國際開發協會第20期增資,以及業經二十國集團核可的現有措施。歡迎多邊開發銀行和國際組織當前工作,并呼吁其在各自授權和預算范圍內加大努力,更好支持對衛生威脅的防范、預防、檢測、應對和控制,并加強相互協調。

16) Seek to ensure the effectiveness of such financing mechanisms, including by leveraging blended finance, innovative mechanisms, public, private, and philanthropic sources, and international financial institution funds. Seek to avoid duplication of efforts, and underline the need for countries to finance their national IHR and R&D capacities, primarily through domestic resources in line with their national circumstances, and mustering support for those unable to do so. Underline the importance of multilateral efforts to meet the financing needs of low- and middle-income countries, including the proposed new general allocation of Special Drawing Rights by the IMF, an ambitious IDA20 replenishment and existing G20 endorsed measures. Welcome the ongoing work of Multilateral Development Banks and International Organisations and call for increase within their mandates and respective budgets their efforts to better support the preparedness, prevention, detection, response, and control of health threats and enhance their coordination. 


(Source: Xinhua)


Go to Forum >>0 Comment(s)

No comments.

Add your comments...

  • User Name Required
  • Your Comment
  • Enter the words you see:   
    Racist, abusive and off-topic comments may be removed by the moderator.
Send your storiesGet more from China.org.cnMobileMobileRSSRSSNewsletterNewsletter